Australia's most trusted
source of pharma news
Wednesday, 08 October 2025
Posted 7 October 2025 PM
Johnson & Johnson Pacific is defending a class action in Australia's Federal Court accusing the company giant of knowingly selling medication that is ineffective.
The class action covers cold and flu medication sold under the Benadryl, Codral, and Sudafed brand names, covering 21 total products now sold by Kenvue, which became a standalone company in 2023 when J&J demerged its consumer healthcare arm.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.